These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2491260)

  • 1. Interleukin 6 and plasma cell neoplasias.
    Hirano T; Kishimoto T
    Prog Growth Factor Res; 1989; 1(3):133-42. PubMed ID: 2491260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias.
    Hirano T
    Int J Cell Cloning; 1991 May; 9(3):166-84. PubMed ID: 2061619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of interleukin 6 in plasmacytomagenesis.
    Hirano T; Suematsu S; Matsusaka T; Matsuda T; Kishimoto T
    Ciba Found Symp; 1992; 167():188-96; discussion 196-200. PubMed ID: 1425013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 6 (IL-6) and its receptor (IL-6R) in myeloma/plasmacytoma.
    Suematsu S; Hibi M; Sugita T; Saito M; Murakami M; Matsusaka T; Matsuda T; Hirano T; Taga T; Kishimoto T
    Curr Top Microbiol Immunol; 1990; 166():13-22. PubMed ID: 2073791
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin-6 and its relation to inflammation and disease.
    Hirano T
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S60-5. PubMed ID: 1728989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6 and its receptor in the immune response and hematopoiesis.
    Hirano T; Taga T; Matsuda T; Hibi M; Suematsu S; Tang B; Murakami M; Kishimoto T
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():155-66; discussion 166-7. PubMed ID: 2324554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytokines and diseases. Abnormal expression of interleukin 6 and diseases].
    Hirano T
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1401-8. PubMed ID: 1761919
    [No Abstract]   [Full Text] [Related]  

  • 8. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
    Akira S; Kishimoto T
    Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 in myeloma/plasmacytoma.
    Suematsu S; Matsusaka T; Matsuda T; Hirano T; Kishimoto T
    Int Rev Exp Pathol; 1993; 34 Pt A():91-8. PubMed ID: 8454420
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin 6 and autoimmunity and plasma cell neoplasias.
    Hirano T
    Res Immunol; 1992 Sep; 143(7):759-63. PubMed ID: 1439152
    [No Abstract]   [Full Text] [Related]  

  • 11. IgG1 plasmacytosis in interleukin 6 transgenic mice.
    Suematsu S; Matsuda T; Aozasa K; Akira S; Nakano N; Ohno S; Miyazaki J; Yamamura K; Hirano T; Kishimoto T
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7547-51. PubMed ID: 2798426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6: possible implications in human diseases.
    Hirano T; Kishimoto T
    Ric Clin Lab; 1989; 19(1):1-10. PubMed ID: 2669108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor.
    Vink A; Coulie P; Warnier G; Renauld JC; Stevens M; Donckers D; Van Snick J
    J Exp Med; 1990 Sep; 172(3):997-1000. PubMed ID: 2388041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines as autocrine growth factors in malignancies.
    Kawano M; Kuramoto A; Hirano T; Kishimoto T
    Cancer Surv; 1989; 8(4):905-19. PubMed ID: 2701735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of IL-6 on proliferation and differentiation of tonsillar lymphocytes and detection of IL-6 producing cells in tonsil.
    Sugiyama M; Uekawa M; Yamane H; Takeda M; Sakamoto H; Nishimoto A; Nakai Y
    Acta Otolaryngol Suppl; 1991; 486():245-53. PubMed ID: 1842872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.
    Schirmacher P; Peters M; Ciliberto G; Blessing M; Lotz J; Meyer zum Büschenfelde KH; Rose-John S
    Am J Pathol; 1998 Aug; 153(2):639-48. PubMed ID: 9708822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diseases associated with cytokine dysregulation].
    Kishimoto T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):724-34. PubMed ID: 8371004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6: historical background, genetics and biological significance.
    Wolvekamp MC; Marquet RL
    Immunol Lett; 1990; 24(1):1-9. PubMed ID: 2197219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 is essential for in vivo development of B lineage neoplasms.
    Hilbert DM; Kopf M; Mock BA; Köhler G; Rudikoff S
    J Exp Med; 1995 Jul; 182(1):243-8. PubMed ID: 7790819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.